SAN JOSE, Calif., Sept. 2, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the time of management's presentation at the H.C. Wainwright 27th Annual Global Investment Conference, being held September 8th – 10th, 2025 in New York City, has been changed to 10:30 AM ET on September 9.Mike Catelani, President and CFO of Anixa, will deliver a presentation and will be available fo ...